Indegene Lifesystems, a leading provider of R&D, commercial and marketing solutions to top global pharmaceutical and healthcare organisations, announced a definitive agreement to acquire the multi-channel, video and e-detailing, and physician marketing services business of Aptilon Holdings, a wholly-owned subsidiary of Aptilon Corporation.
Aptilon, headquartered in Canada, is a pioneer and a leader in providing e-marketing solutions for several large pharma, biotech and healthcare clients in the US, Canada and Europe. Aptilon enables clients to effectively reach, connect and interact with over 500,000 physicians and healthcare professionals via multiple access channels including iPADs, mobile and desktop media. Its innovative service and platform offerings, including Live Central and Channel HQ, provide targeted impressions and interactions through “click-to-talk” video and mobile detailing, digital access ‘on-demand’ channels and permission-based email services that drive efficient physician recruitment and outcomes.
The need for intelligent, robust, and outcome-driven multi-channel marketing (MCM) and Virtual/Inside Sales programmes is estimated to represent a $10 billion opportunity as companies continue to accelerate the transformation of their sales and marketing organizations over the next four to five years.
Manish Gupta, CEO, Indegene, said “By combining Indegene’s Virtual/Inside Sales and MCM capabilities with Aptilon’s technology platforms, significant physician reach, and multi-year data on physician behaviour in the North American and European market, clients can accelerate their physician engagement strategies and deploy true end-to-end world-class programmes.”
Denis Martineau, President, Aptilon Holdings, added, “Aptilon has been a leading provider of world-class eMarketing, remote detailing and multi-channel marketing programs. Through this proposed transaction, our clients will gain access to an accelerated approach to drive integrated physician engagement programmes. In addition, our clients can leverage global expertise and infrastructure assets in the US, Europe and emerging markets to enhance productivity as well as effectiveness.”
Upon completion of the acquisition, Aptilon’s multi-channel, e-detailing, and physician marketing services businesses will be rolled under Indegene Aptilon, a wholly-owned subsidiary of Indegene Lifesystems.
Dr Rajesh Nair, President, Indegene, said “Indegene has been a leading provider of digital and multi-channel marketing solutions to global pharma since early adopters started to transform their sales and marketing organisations. We have implemented close to 100 global and local programmes, and now have over 300 full-time MCM and Virtual/Inside sales professionals based in the US, India and China. We have also added over 20 strategic contact centre partnerships globally to enable clients to deploy multi-country/multi-regional/multi-lingual sales and MCM programmes for both new and mature products.”
Nair added, “This acquisition presents us with a unique opportunity to further consolidate our Virtual/Inside sales offering. We expect the synergies of this acquisition to create around 200 new jobs in the US and Canada, and an additional 1,000 jobs in India and China as we ramp up to address this need. We expect to complete this transaction in the next few weeks subject to customary closing conditions including obtaining necessary approvals from regulatory authorities.”
EP News Bureau
- Advertisement -
